FainsingerRL, MacEachernT, MillerMJ, BrueraE, SpachynskiK, KuehnN, HansonJ.The use of hypo-dermoclysis for rehydration in terminally ill cancer patients. J Pain Sympt Manag1994; 9(5): 298–302.
15.
SieglerM, WeisbardAJ. Against the emerging stream: should fluids and nutritional support be discontinued? Arch Intern Med1985; 145: 129–131.
16.
RosnerF.Why nutrition and hydration should not be withheld from patients. Chest1993; 104(6): 1892–1896.
17.
CraigGM. On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? J Med Ethics1994; 20: 139–143.
18.
CookDJ, SackettDL, SpitzerWO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-analysis. J Clin Epidemiol1995; 48(1): 167–171.
19.
DoyleD (ed). Palliative Care: The Management of Far-Advanced Illness. Beckenham: Croom Helm, 1984.
20.
ZimmermanJM. Hospice — Complete Care for the Terminally Ill. Baltimore: Urban & Schwarzenberg, 1986.
21.
MosleyJG. Palliation in Malignant Disease. Edinburgh: Churchill Livingstone, 1988.
22.
LynnJ (ed). By No Extraordinary Means — The Choice to Forgo Life-Sustaining Food and Water. Bloomington: Indiana University Press, 1989.
BrueraE, LegrisMA, KuehnMiller M.Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer (letter). J Nat Cancer Inst1989; 81(14): 1108–1109.
34.
BrueraE, LegrisMA, KuehnN, MillerMJ. Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer. J Pain Sympt Manag1990; 5(4): 218–220.
35.
BrueraE, SchoellerT, PruvostM.Proctoclysis for hydration of terminal cancer patients (letter). Lancet1994; 344: 1699.
36.
BrueraE, de StoutzND, FainsingerRL, SpachynskiK, Suarez-AlmazorM, HansonJ.Comparison of two different concentrations of hyaluronidase in patients receiving one-hour infusions of hypodermoclysis. J Pain Sympt Manag1995; 10(7): 505–509.
37.
BrueraE, BelzileM, WatanabeS, FainsingerRL. Volume of hydration in terminal cancer patients. Support Care Cancer1996; 4: 147–150.
38.
BurgeF.Dehydration symptoms of palliative care cancer patients (thesis). Montreal: McGill University, 1990.
39.
WallerA, HershkowitzM, AdunskiA.The effect of intravenous fluids infusion on blood and urine parameters of dehydration and state of consciousness (abstract). J Palliat Care1990; 6(3): 61.
McCannR, HallW, Groth-JunckerA, RobertsMA. Comfort care for terminally ill patients: the appropriate use of nutrition and hydration (abstract). J Am Geriatr Soc1992; 40: SA8.
42.
BrueraE, FrancoJJ, MaltoniM, WatanabeS, Suarez-AlmazorM.Changing pattern of agitated delirium in patients with advanced cancer: association with cognitive monitoring, hydration, and opiate rotation (abstract). J Palliat Care1994; 10(4): 56.
43.
MusgraveCF, BartalN, OpstadJ.Fluid retention and intravenous hydration in the dying (letter). Palliat Med1996; 10(1): 53.
44.
SmithSA. Patient-induced dehydration — can it ever be therapeutic? Oncol Nurs Forum1995; 22(10): 1487–1491.
45.
BurgeFI. Dehydration symptoms of palliative care cancer patients. J Pain Sympt Manag1993; 8(7): 454–464.
46.
McCannRM, HallWJ, Groth-JunckerA.Comfort care for terminally ill patients: the appropriate use of nutrition and hydration. JAMA1994; 272(16): 1263–1266.
47.
WallerA, HershkowitzM, AdunskyA.The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients. Am J Hospice Palliat Care1994; 11(6): 22–27.
48.
EllershawJE, SutcliffeJM, SaundersCM. Dehydration and the dying patient. J Pain Sympt Manag1995; 10(3): 192–197.
49.
BrueraE, FrancoJJ, MaltoniM, WatanabeS, Suarez-AlmazorM.Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Sympt Manag1995; 10(4): 287–291.
50.
MusgraveCF, BartalN, OpstádJ.The sensation of thirst in dying patients receiving IV hydration. J Palliat Care1995; 11(4): 17–21.
51.
CollinsR, DollR, PetoR.Ethics of clinical trials. In: WilliamsCJ (ed). Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems. Chichester: John Wiley and Sons, 1992; pp. 49–65.
52.
CohenSR, MountBM. Quality of life in terminal illness: defining and measuring subjective well-being in the dying. J Palliat Care1992; 8(3): 40–45.
53.
SterkenburgCA, KingB, WoodwardCA. A reliability and validity study of the McMaster Quality of Life Scale (MQLS) for a palliative population. J Palliat Care1996; 12(1): 18–25.
54.
CohenSR, MountBM, SfrobelMG, BuiF.The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med1995; 9: 207–219.
55.
ScottJF, MacDonaldN.Education in palliative medicine. In: DoyleD, HanksGWC, MacDonaldN (eds). Oxford Textbook of Palliative Medicine. New York: Oxford University Press, 1993; pp. 761–781.
56.
MoherD, FortinP, JadadAR, JuniP, KlassenT, Le LorierJ, LiberatiA, LindeK, PennaA.Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet1996; 347: 363–366.
57.
FinkA, KosecoffJ, ChassinM, BrookRH. Consensus methods: characteristics and guidelines for use. Am J Public Health1984; 74(9): 979–983.